NTA and analysis of the exosome marker CD81 revealed that Exo-RA had a significantly higher number of exosomes compared to Exo-FBS, and the amounts of TGF-β1 were significantly higher in Exo-RA than those in Exo-FBS. The gene discussed is CD81; the disease is rheumatoid arthritis.